Valuation: Microbot Medical Inc

Capitalization 34.37M 33.19M 31.42M 27.69M 49.2M 2.99B 54.88M 375M 138M 1.24B 129M 126M 5.32B P/E ratio 2024 *
-
P/E ratio 2025 * -
Enterprise value 34.37M 33.19M 31.42M 27.69M 49.2M 2.99B 54.88M 375M 138M 1.24B 129M 126M 5.32B EV / Sales 2024 *
-
EV / Sales 2025 * 5.73x
Free-Float
58.27%
Yield 2024 *
-
Yield 2025 * -
More valuation ratios * Estimated data
Director TitleAgeSince
Chief Executive Officer 53 1988-08-01
Director of Finance/CFO 46 2022-03-31
Chief Tech/Sci/R&D Officer - 2023-11-30
Manager TitleAgeSince
Chairman 53 2012-12-31
Director/Board Member 60 2016-11-27
Director/Board Member 65 2017-02-05
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi.($)
-1.68%-2.35%+33.97%-0.73% 48.19B
-1.83%-3.97%-9.51%-17.82% 35.38B
-0.56%+0.73%+4.47%+23.12% 26.25B
+0.14%-4.47%-32.52%-26.66% 15.47B
+4.05%+4.41%+71.00%+82.31% 15.77B
-1.65%-12.84%-65.74%-78.60% 11.9B
-0.94%-10.23%-3.42%-34.67% 10.8B
+1.38%-6.62%+2.30%+90.35% 10.02B
+2.94%+6.61% - - 11.21B
Average +0.29%-1.29%+0.07%+4.66% 20.56B
Weighted average by Cap. -0.36%-0.78%+7.13%+2.43%
See all sector performances

Financials

2024 *2025 *
Net sales - 6M 5.79M 5.49M 4.83M 8.59M 521M 9.58M 65.48M 24.17M 217M 22.49M 22.04M 929M
Net income - -
Net Debt - -
More financial data * Estimated data
Logo Microbot Medical Inc
Microbot Medical Inc. is a pre-clinical medical device company. The Company is specializing in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is primarily focused on leveraging its robotic technologies with surgical robotics to improve surgical outcomes for patients. Its technological platforms include LIBERTY and NovaCross. Using its LIBERTY Endovascular Robotic Surgical System, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. It eliminates the need for capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. LIBERTY Endovascular Robotic Surgical System addresses the needs of interventional cardiology, interventional radiology and interventional neuroradiology markets.
Employees
-
More about the company